Copyright © Panorama Medicine. All rights reserved.

ACCELERATE DRUG DISCOVERIES USING GENOMICS AND COMPUTING

RNA splicing is a fundamental mechanism in molecular biology in which segments of messenger RNAs (mRNAs) are either retained or cut-out from the final transcript in a context dependent manner. The ability to selectively include or exclude portions of an mRNA allows the production of multiple mRNAs and hence multiple proteins from a single gene. Founded by world-renowned computational and experimental RNA biologists, Panorama integrates genomics, big data, and computing to develop therapeutic interventions for RNA defects in a wide variety of disease. Our proprietary genome-wide drug screening platform targets diseases treatable through modulation of RNA splicing.
 

 
 

TEAM

FOUNDERS

Douglas Black
Yi Xing
Board Member
Mingfu Zhu,
Board Member & CEO

ADVISORS & BOARD

Beverly Davidson
Scientific Advisor
Rod Ferguson
Business Advisor
Maxine Gowen
Board Member
Jimmy Lu
Board Member

TEAM

Steve Anderson
Jonathan Freshman
Lisa Nguyen
Christy Rhine

LATEST NEWS

 

INVESTORS

20180725190411805.png
wi-harper-group.jpg
zhen-fund_owler_20160227_001955_original

JOIN OUR TEAM

Panorama is always looking for talented individuals interested in working to improve the lives of people with severe genetic disease.

Consider joining our team.
 

CONTACT US

Suite 603, 2 Bala Plaza, Bala Cynwyd, PA 19004